CTNNA3 and cancer: CTNNA3[15] and TUSC3[23], which have also been cited as candidate TSGs for the same reason, could also have their status as TSG re-evaluated in light of our results, given that for each of these genes we have identified a number of cancer-free adult individuals with exon-disrupting deletions (Table 1).